Chief Science Officer, Metabiota
San Francisco, CA
Dr. Eddy Rubin is Chief Science Officer of Metabiota, the pioneering risk analytics company that improves the world’s resilience to epidemics.
Prior to joining Metabiota, Dr. Rubin acted as the Director of the DOE Joint Genome Institute (JGI). The JGI is a large genomic facility and was a major participant in the Human Genome Project under his leadership, sequencing 13 per cent of the human genome as well as the genomes of thousands of microbes, viruses and fungi.
His research has included a series of pioneering studies in the area of metagenomics, deriving important insights from his investigation of the microbial communities inhabiting a variety of environments.
Dr. Rubin has published over 250 peer-reviewed manuscripts with more than 35 of them appearing in the journals Science and Nature. In addition to being a member of the Genome Canada Board of Directors, he is Chair of the Genomic Institute of Singapore’s Scientific Advisory Board and was a member of the Welcome Trust Sanger Center’s Scientific Advisory Board from 2008-2012.
He received an Honorary Doctorate of Science from Middlebury College, the University of Rochester Dean’s Award, the Netherlands Heart Association Declaration of Esteem, the American Heart Association Established Investigator Award, and has been inducted into the American Society of Clinical Investigation. He served as a member of the Board of Reviewing Editors for the journal Science from 2001 to 2012. Dr. Rubin received a BA in Physics at the University of California San Diego, his MD & PhD (Biophysics) at the University of Rochester, and completed his clinical training in Human Genetics at the University of California San Francisco.